Historical and existing techniques
Three decades ago, several techniques had been developed to provide rapid ligand application to an excised cell soma or a cell membrane patch. A side-pore perfusion system 4 and a single-filament application probe driven by a piezo element 5 were described in the 1980s. Subsequently, various experimental systems were implemented that enable application of multiple solutions to the recorded patch, such as a piezo-driven multicapillary application pipette 6 , U-tube perfusion 7 or a plumbing flow-exchange method 8 . Repeated application of different solutions within the lifetime of a membrane patch (1-5 min) should be a crucial advantage in many experimental designs: successive pharmacological manipulations on the same receptor pool (e.g., to document activation, washout, blockade and so on) are key to the reliable receptor characterization and, in turn, to the development of pharmacological tools. However, the aforementioned techniques operate with ligand exposure times exceeding 10-100 ms, which is substantially slower than extracellular neurotransmitter transients generated locally by small central synapses. To achieve sub-millisecond application times in excised patches (outside organized tissue), a system was therefore developed, which relied on a double-barrel (θ-glass) piezo-driven micropipette [9] [10] [11] [12] [13] , with an estimated time response limit of ~20 µs (ref. 14) . Inside organized tissue, fast application times could be achieved, albeit with little control over precise ligand concentrations, by using common iontophoretic electrode ejection with a two-pipette (source-sink) system 15 , or, more recently, by using rapid photolytic neurotransmitter release (uncaging) 16 . It would be important, however, to combine sub-millisecond ligand application with the capacity of multiple solution exchange. The elegant method of a hydraulic flow switch 17 can in principle provide this combination, but it has some crucial limitations, especially in experiments involving membrane patches excised from cells in situ. First, multiple application capillaries are mounted on the objective providing a prefixed focal plane site where the application takes place 17 . This must restrict, if not entirely prevent, microscopic exploration of tissue and selection of target cells in situ. Second, the method uses aqueous streams flowing from different directions: a rapid switch between such streams can introduce a mechanical concomitant and shorten preparation lifetime, especially with relatively bulky nucleated patches (somatic envelopes).
Experimental design
Our aim was to develop a simple technique in which ligand solutions applied with the piezo-driven θ-glass pipette could be fully replaced during the lifetime of individual cell membrane patches (1-5 min). To achieve this, we introduced several modifications described below and termed thereafter a rapid application and solution exchange (RASE) protocol. The approach has been validated in several of our research publications, as illustrated below, involving not only the standard outside-out membrane patches but also larger nucleated patches (nucleus-containing somatic envelopes) that preserve the somatic milieu in tested cells.
It has been noted previously that, with the θ-glass configuration, the flow velocity has to be below 100-150 µm ms − 1 to avoid damaging the patch and that the optimal pipette tip diameter must be ~200 µm. Although rapid application relies on the mechanics of the piezo-driven θ-glass pipette tip movements, the replacement of applied solutions inside the two barrels depends on rapid solution supply from the back end. The supply could be arranged by having, inside the barrels, one or more flexible microfilaments connected to a pressurized microtube circuit. However, this arrangement typically yields a relatively slow rate of solution exchange, most likely due to a relatively large dead volume (buffering capacity) inside θ-glass channels, leading to a substantial initial dilution and local vortex formation. Speeding up the exchange by increasing supply pressure is counteracted by the considerable viscous resistance in the thin filaments and can also damage the patch. We therefore set out to increase the solution exchange rate by reducing the dead solution volume inside the θ-glass pipette.
Multiple-circuit application pipette. We set out to have three or four supply circuit microfilaments in each θ-glass channel while maximally reducing the solution exchange volume (Fig. 1a) . To achieve this, we developed the procedure as follows. First, we inserted three microfilaments in one θ-glass barrel roughly realigning their ends near the pipette tip (Fig. 1b) . Second, we connected a fourth microfilament to a syringe filled with a rapidly setting, water-resistant glue and inserted it into the same channel (Fig. 1b, image 3) . Pressure was applied to inject the glue into the glass-channel filling before it reached the three filament ends (Fig. 1b) . The procedure was repeated for the other θ-glass barrel (Fig. 1b) . Once the glue was set, the pipette was ready for use ( Fig. 1c) and could be mounted on the piezo-actuator attached to a standard microelectrode holder (Fig. 1d) and electrically connected to a standard constant-voltage stimulus isolator. The pipette mount was made out of a three-way plastic tubing adaptor, with one branch cut off to provide a channel for the tightening screw (Fig. 1d, inset) . Pressurized circuit for multiple solution exchange. In the typical configuration, the solution supply circuit contained three plastic solution containers (from a blood dialysis kit) for each pipette barrel. Each of these containers was connected to a pressure supply line and was equipped with three-way taps and a replaceable stopcock ( Fig. 2a,b) . Two separate pressure supplies (standard micropumps) were normally required to adjust and equalize pressure and therefore the ejected stream speed, between the two barrels (which normally show slightly different hydraulic resistance). Application solutions could be added to each container independently through a three-way tap with a stopcock removed to siphon the air inside ( Fig. 2a,b) . Because switching the solution supply is likely to generate pulses of excessive pressure, pressure-buffering microfilters were inserted between the solution container and each loading capillary (Fig. 2c) .
Optimizing pipette position and speed. To ensure the fastest possible application time, the membrane patch needs to be as close as possible to the piezo-driven application pipette. At the same time, it is important to avoid flow distortions and fluctuations in the streams when they exit the θ-glass and meet at the end of the glass dividing wall (septum) (Fig. 3a) . We therefore routinely placed a recording pipette at a distance of 20-30 µm from the tip and further adjusted its position using the water test ( Fig. 3b and Supplementary Video 1). Positioning the patch at some distance from the θ-glass pipette has another important advantage: because of the brief delay between the θ-glass movement onset and the time the mechanical wave reaches the recorded patch, there is a clear time lag between the electrical artifact from the piezo-actuator switch and the actual membrane receptor response (Fig. 3b) . This can be helpful in separating the pulse from the concomitant artifact. A small piece of silicone inserted into the θ-glass pipette holder under the tightening screw (Fig. 1d) and the use of shorter pipettes (where possible) can also help in reducing flow fluctuations (Fig. 3a) . The speed at which the application solution switches depends on the rate of piezo-actuator bending and the length of the application θ-glass pipette attached to it. This speed could be boosted, at least in theory, either by strengthening the electrical pulse applied to the piezo actuator or by using longer pipettes (and thus speeding up their tip movement). In practice, however, increasing the pipette length leads to concomitant problems such as increased tip vibration and reduced pipette maneuverability. In addition, longer θ-glass pipettes require longer loading microfilaments, thus increasing viscous resistance to solution flow. Maintaining the correct temperature of the applied solution is important for reliable characterization of tested receptors. Therefore, in order to ensure temperature equilibration, the tip of the θ-glass pipette should be submerged into perfusion solution for at least 4-5 mm before starting the recording session. Temperature control in the application streams can be performed by placing a microthermocouple (e.g., Cole-Palmer Type-K, straight-shaft microprobe, tip diameter ~100 µm, precision ± 1 °C) at the position of the patch recording electrode tip.
Experimental validation
The present RASE protocol has been validated in our recent studies, in which cell patches were excised from acute brain slices, focusing on hippocampal CA1 pyramidal cells [18] [19] [20] , granule cells 21 , cerebellar granule cells (CGCs) 18, 20 and cultured CGCs 18 . In one example 21 , we tested the solution exchange system on its own, by recording single-channel currents of γ-aminobutyric acid A (GABA) A receptors to establish receptor sensitivity to GABA and to the common antagonists (Fig. 4a,b ). An example from another recent study 18 reveals the sensitivity of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptors to the competitive antagonist γ-d-glutamylglycine when 1 mM-1 ms pulses of glutamate are applied in a single patch from CA1 pyramidal cells (Fig. 4c) .
In a related work, the RASE enabled us to test a hypotheses according to which perisynaptic group I metabotropic glutamate receptors (mGluRs) could rapidly, on a sub-millisecond scale, boost local synaptic N-methyl-d-aspartate (NMDA) receptor (NMDAR) currents in CGCs 20 . Our experimental objectives thus were to enable receptor probing on a sub-millisecond scale, to isolate receptor responses from any network influences and to preserve, as much as possible, the postsynaptic protein machinery. We therefore carried out RASE experiments in nucleated patches of CGCs (Fig. 5a ): we applied a 1-ms pulse of 1 mM glutamate (plus 1 mM glycine) to compare evoked NMDAR currents between control conditions and after adding group I mGluR antagonists LY367385 (LY, 100 µM) and 2-methyl-6-(phenylethynyl)pyridine (MPEP, 200 nM) to both θ-glass barrels (solution exchange took ~10 s). The NMDAR specificity in the patch was further tested using a third solution exchange, which added the NMDAR antagonist APV (50 µM). We found that NMDAR responses to the same pulse, in the same membrane patch, were inhibited by group-I metabotropic glutamate receptor (mGluR) antagonists (Fig. 5b) . This result indicated that a 1-ms exposure of mGluRs to glutamate was sufficient to boost NMDAR currents activated by the same glutamate pulse. This effect was not due to contaminant actions of LY + MPEP or the constituent activity of mGluRs because the same experiment with NMDA applied instead of glutamate showed no mGluR blockade on NMDARs ( Fig. 5c ; see further data and detailed explanations in the original research report 20 ).
Advantages and limitations
The principal advantage of RASE is that it allows the application of several different ligands in a single rapid solution application experiment probing the same receptor pool. Because the effect of interest could be relatively modest and/or smaller than the variation between cells or patches recorded in separate experiments, the RASE protocol greatly enhances the experimental design through the use of paired-sample statistics. Combined with recordings from nucleated patches, RASE also allows experimental separation of the effects pertinent to the intracellular machinery of receptor action on the sub-millisecond scale. In a more general context, RASE could be applied to the fields of research outside patchclamp electrophysiology, such as protein-ligand interactions in biophysical or biochemical assays, non-neuronal cell physiology or materials science. There are several potential limitations of RASE. First, in the case of nerve cells, this and similar rapid application techniques are designed to probe predominantly extrasynaptic receptors exposed to the application medium. Indeed, we have recently shown that the externally applied concentration pulse is slowed down while reaching target receptors inside the synaptic cleft 20 . Second, because of the variable characteristics of θ-glass pipettes (profile of the tip, size of the dead space inside, widths of the two barrels and so on) such pipettes should be individually calibrated to find a suitable pressure in each channel, the amplitude and duration of the electric switching pulse and the recording pipette position. Third, in nucleated patches, the turbulence at the patch side opposite to the application side could have a variable (albeit relatively small) effect on the kinetics of recorded receptor responses. In our experience, however, this concomitant effect could be satisfactorily averaged out with an increased number of recorded individual traces.
Below we detail the RASE protocol setup for recording of receptor responses to sub-millisecond application of receptor ligands. Here we routinely refer the reader to the textbook details of brain slice preparation, whole-cell patch-clamp methods [22] [23] [24] , the outside-out patch technique 25 and nucleated patch configuration 26 patches. Therefore, standard electrophysiological procedures and equipment will not be discussed unless they are specifically important to the procedure or to its troubleshooting. Substantial hands-on experience in standard electrophysiological patch-clamp techniques is expected for a successful implementation of the present protocol.
MaterIals

REAGENTS
In vitro preparation. • proceDure assembling the rapid application pipette • tIMInG 1-2 h (excluding glue setting) 1| Pull the solution application pipette with a ~200-µm tip from θ-glass capillary using a standard pipette puller and fix it under a low-magnification binocular microscope, e.g., using blue tack (Fig. 1b) .
2|
Insert the supply microfilaments into one barrel and fix them in a position, e.g., with a piece of blue tack placed near the pipette blunt end (Fig. 1b) .
3|
Insert another freely moving microfilament connected to a syringe filled with glue (Fig. 1b) .
4| Gently eject the glue by applying pressure with the syringe; stop ejection when the glue approaches the ends of the supply microfilaments (Fig. 1b) .  crItIcal step The stop point should be at least 1.5-2-mm away from the ends of the supply microfilaments. This is to prevent drawing of the glue inside the filaments by capillary forces. ? trouBlesHootInG 5| Slowly remove the filament connected to the syringe with glue; if you experience difficulty, leave it inside the barrel and later cut at a pipette end.
system maintenance • tIMInG 20-30 min 20| After an experiment, thoroughly rinse the whole setup (pressurized solution supply system, θ-glass pipette) with ~20% (vol/vol) ethanol and distilled water, and then blow it dry with an inert gas at high pressure.  crItIcal step The θ-glass pipette tip and, especially, loading microfilaments are extremely sensitive to blocking with dust and precipitated crystals. Therefore, it is absolutely necessary to treat all used solutions using 4-10-µm filters and to perform extensive rinsing after each experiment. ? trouBlesHootInG ? trouBlesHootInG assembling the rapid solution application set (step 4)
The most crucial step in this preparation is the filling of θ-glass pipette with glue: capillary forces tend to draw the glue into the loading microfilaments and also toward θ-glass pipette tip. To overcome this, a drop of water can be placed at the sharp end of the pipette: on being pulled into the pipette tip by capillary forces, it forms a meniscus. Because the cyanoacrylate glue hardens rapidly upon contact with water, the water meniscus stops its progress toward the pipette end. If the minimal dead volume is not a crucial requirement (e.g., in experiments in which tested patches survive for longer than several minutes), filling with the glue can be stopped near the blunt end of the θ-glass pipette.
optimizing the pressurized solution supply system (step 12) When the θ-glass pipette septum is not parallel to the piezo-bending actuator and/or the piezo-bending actuator is not perpendicular to the line of sight, it makes the system calibration much harder. In these conditions, it becomes difficult to optimize stimulus isolator settings and the recording pipette position (that provides a rapid enough switch between solutions). Therefore, one should pay attention when inserting the solution application pipette into the pipette holder and clamping the actuator rod in the micromanipulator holder.
system maintenance (step 20) Small amounts of solutions tend to accumulate toward the pipette tip because of the capillary force. It is sometimes virtually impossible to dry this remaining liquid even with gas blowing, and precipitated crystals can sometimes block the pipette tip, thus rendering the pipette unusable. To avoid this, after rinsing the pipette, dry it by touching its tip with a soft (lens) paper tissue, which absorbs the remaining solution.
• tIMInG Steps 1-12, assembling a rapid solution application set: 1 d; it is recommended that 5-7 sets should be manufactured and left overnight to let the superglue set Steps 13-18, system calibration and experimental setting: 2-4 h, depending on the overall quality of prepared application sets
Step 19, protocol implementation in a patch experiment: 20-60 min, depending on the particular experimental design
Step 20, system maintenance: 20-30 min after the end of experimentation
antIcIpateD results
The expected results will comprise traces of the receptor current recorded from individual outside-out or nucleated patches, normally divided into trial sweeps of 100-1,000 ms in length (Figs. 4 and 5) . These data are routinely stored offline as binary or text files for subsequent analyses. The total number of trials per experiment is highly variable and depends on the patch stability and the particular experimental design. With a typical signal-to-noise ratio in this type of experimental recording, each experimental epoch (baseline-ligand-washout) should include at least three to five individual trials to ensure appropriate final averaging. Measured parameters of averaged traces should be analyzed using standard statistical methods, with an advantage of having real-time pharmacological manipulations in the same patch, thus enabling powerful paired-sample statistical tests. Normally, only one outside-out or nucleated patch is recorded in each individual acute brain slice with the RASE protocol, to avoid both contamination of the perfusion solution and accumulation of applied drugs in the tissue. autHor contrIButIons S.S. carried out the experimental studies; D.A.R. and S.S. designed the protocol, analyzed the data and wrote the paper.
